The Ray and The Ro

Ever since 2019, the healthcare sector has been white-knuckling and preparing itself for what may be a volatile and uncertain election year for stocks. But according to…

Good morning. Critics of the movement toward “stakeholder capitalism” like to argue that until corporate accounting and governance rules change, shareholder primacy will reign supreme. (If you…

Pascal Soriot, the chief executive of pharmaceutical giant AstraZeneca, has defended his company’s transparency amid criticism it has not been forthcoming enough about safety concerns that led…

Fresh off a summer of relative freedom after harsh lockdowns at the beginning of the pandemic, Europe is trying a new strategy to halt the coronavirus’s next…

The U.K. government is considering carrying out the first studies that would deliberately expose healthy people to the coronavirus in a bid to accelerate the development of…

This is the web version of the Bull Sheet, Fortune’s no-BS daily newsletter on the markets. Sign up to receive it in your inbox here. Good morning. Yesterday’s…

What would you risk for a better life? That’s a question Central Americans have been grappling with for decades. Most have two choices. They can head north…

A coronavirus vaccine won’t be a silver bullet against the COVID pandemic, but public health experts say it’s an important step that could start the process of…

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism, subscribe today. Tesla’s Battery Day on Tuesday was…

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism, subscribe today. During the past few years, many…